Abstract
Copy number variants (CNVs) affecting the NRXN1 gene (NRXN1del) are associated with ASD, intellectual disability/developmental disorder, epilepsy, and other neurodevelopmental symptoms. NRXN1dels belong to the “synaptopathies” group, which are disorders disrupting the synaptic function of genes. Deep phenotyping of NRXN1del carriers could link clinical outcomes to neurobiology and progress biomarker discovery. We are studying carriers as part of the SynaG study, within the AIMS-2-TRIALS study. We use a genotype-first approach to assess if a genetic change is related to a clinical outcome or intermediate phenotype, for example, a cognitive, behavioral, or brain-based difference.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
